Quaisar Medisoft Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.45 M
as on 24-10-2024
- Revenue 16.83%
(FY 2023)
- Profit -280.35%
(FY 2023)
- Ebitda -34.68%
(FY 2023)
- Net Worth -13.15%
(FY 2023)
- Total Assets -6.03%
(FY 2023)
About Quaisar Medisoft
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.45 M.
Naheed Quaisar, Sirajuddin, Priyanka Baya, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232RJ2006PTC022566
- Company No.
022566
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2006
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quaisar Medisoft?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Baya  | Director | 01-Jun-2021 | Current |
Naheed Quaisar  | Director | 26-May-2006 | Current |
| Sirajuddin | Director | 26-May-2006 | Current |
| Sherebanu Ajmerwala | Director | 27-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Quaisar Medisoft.
Quaisar Medisoft Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.83% increase. The company also saw a substantial fall in profitability, with a 280.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quaisar Medisoft?
In 2023, Quaisar Medisoft had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Mar 2021 | ₹0.45 M | Open |
How Many Employees Work at Quaisar Medisoft?
Quaisar Medisoft has a workforce of 92 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quaisar Medisoft, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quaisar Medisoft's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
